Answers are grounded in this paper and cite their sources.
RTX can be safely administered and may be an effective agent to reduce high-titer anti-HLA Abs in subjects awaiting kidney transplantation.
No takes yet. Share an insight, caveat, or question.
Vieira et al. (2004) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: